Suggestions
Ignacio Lara
Global Executive of Pharmaceutical Business - Digital Strategy, Brand Marketing, Customer Experience and Innovation
Professional Background
Ignacio Quiles Lara is a highly skilled and accomplished senior executive with over 15 years of extensive managerial and hands-on experience in the oncology therapeutic area. His career trajectory has been marked by significant contributions in pharmaceutical global, regional, and local leadership—spanning markets in the USA, EU, Latin America, Spain, France, and Brazil. Ignacio has garnered a wealth of knowledge in commercial leadership, strategic direction, and business development, excelling in a variety of operational and strategic roles.
Throughout his career, Ignacio has demonstrated a proven ability to drive molecules to become leading oncology therapies that significantly improve patient outcomes. He has played a pivotal role in the development of several groundbreaking oncology medicines, including notable products such as Venclexta, Tafinlar, Zykadia, Jakavi, Piqray, Rydapt, Kisqali, and Afinitor. These treatments address a range of oncology indications, including breast cancer, lung cancer, kidney cancer, melanoma, and various hematologic malignancies.
Ignacio's visionary leadership has not only fostered innovation in oncology but has also created opportunities for healthcare professionals and patients alike to access high-quality therapies that can enhance their quality of life. His focus on strategic initiatives and his ability to adapt to rapidly changing market dynamics have positioned him as a trusted leader in the pharmaceutical industry.
Education and Achievements
Ignacio Quiles Lara is not only recognized for his contributions to the field of oncology but also for his commitment to ongoing education and professional development. He holds a degree in medicine, which lays the foundation for his scientific understanding and approach to drug development and patient care. Throughout his career, Ignacio has remained engaged with the latest trends in the oncology landscape, frequently attending international congresses and speaking engagements where he shares his insights and expertise with fellow professionals.
In addition to his professional prowess, Ignacio's achievements in developing high-performing organizational cultures are noteworthy. His leadership style emphasizes trust, empowerment, and open communication, fostering an environment where teams are encouraged to thrive and innovate. This approach has not only enhanced team performance but has also contributed to the overall organizational success.
Personal Interests
Beyond his exceptional professional achievements, Ignacio is an individual with diverse interests that reflect his adventurous spirit. He is passionate about extreme sports, which parallels his dynamic approach to life and work, embodying a sense of resilience and determination. This passion for adventure informs his leadership style, where he motivates those around him to push boundaries and achieve their goals.
Ignacio's engaging personality, combined with his emotional intelligence, allows him to connect with colleagues and stakeholders at all levels. His genuine interest in developing professionals reinforces his commitment to cultivating a collaborative and innovative organizational culture.
Overall, Ignacio Quiles Lara exemplifies a leader who combines scientific expertise with a passion for patient care, making remarkable strides in the oncology therapeutic area while fostering environments that encourage growth and excellence. Whether through his work in drug development or his inspiring leadership style, Ignacio continues to leave a positive imprint on the pharmaceutical industry and the lives of countless patients.
Achievements
Ignacio has played a pivotal role in the development and commercialization of numerous leading oncology medicines, showcasing his aptitude in transforming innovative insights into market-ready therapies. He stands out for his strategic vision, adaptability, and commitment to ensuring that new oncology treatments are accessible to those in need. His significant contributions have not only advanced cancer care but have also positioned him as a thought leader and trusted executive within the pharmaceutical community.